Parkinson's disease sleep scale-validation of the revised version PDSS-2

Background: The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients. Objective: To extend the scale so that it becomes a frequency measure scale with five categories and...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Movement disorders Ročník 26; číslo 4; s. 644 - 652
Hlavní autori:	Trenkwalder, Claudia, Kohnen, Ralf, Högl, Birgit, Metta, Vinod, Sixel-Döring, Friederike, Frauscher, Birgit, Hülsmann, Julia, Martinez-Martin, Pablo, Chaudhuri, Kallol Ray
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.03.2011 Wiley Subscription Services, Inc
Predmet:	Adult Aged Aged, 80 and over Factor Analysis, Statistical Female Humans Male Middle Aged MOS Movement disorders nocturnal disturbance Parkinson Disease - complications Parkinson's disease PDSS Reproducibility of Results Severity of Illness Index sleep Sleep Wake Disorders - diagnosis Sleep Wake Disorders - etiology Statistics as Topic Surveys and Questionnaires UPDRS validation
ISSN:	0885-3185, 1531-8257, 1531-8257
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Background: The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients. Objective: To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea. Methods: For validation of the PDSS‐2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS‐2 was repeated for test‐retest‐reliability after 1–3 days. Results: A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2–40) indicating mild to moderate sleep disturbances. PDSS‐2 item‐total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) “motor problems at night,” (2) “PD symptoms at night” and (3) “disturbed sleep.” The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test‐retest‐reliability intra‐class‐coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS‐2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out. Conclusion: The PDSS‐2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment‐responsive tool for measuring sleep disorders in PD. © 2011 Movement Disorder Society
AbstractList	The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients. To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea. For validation of the PDSS-2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS-2 was repeated for test-retest-reliability after 1-3 days. A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2-40) indicating mild to moderate sleep disturbances. PDSS-2 item-total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) "motor problems at night," (2) "PD symptoms at night" and (3) "disturbed sleep." The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test-retest-reliability intra-class-coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS-2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out. The PDSS-2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment-responsive tool for measuring sleep disorders in PD. Background: The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients. Objective: To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea. Methods: For validation of the PDSS-2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS-2 was repeated for test-retest-reliability after 1-3 days. Results: A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2-40) indicating mild to moderate sleep disturbances. PDSS-2 item-total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) "motor problems at night," (2) "PD symptoms at night" and (3) "disturbed sleep." The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test-retest-reliability intra-class-coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS-2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out. Conclusion: The PDSS-2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment-responsive tool for measuring sleep disorders in PD. © 2011 Movement Disorder Society Background: The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients. Objective: To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea. Methods: For validation of the PDSS‐2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS‐2 was repeated for test‐retest‐reliability after 1–3 days. Results: A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2–40) indicating mild to moderate sleep disturbances. PDSS‐2 item‐total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) “motor problems at night,” (2) “PD symptoms at night” and (3) “disturbed sleep.” The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test‐retest‐reliability intra‐class‐coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS‐2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out. Conclusion: The PDSS‐2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment‐responsive tool for measuring sleep disorders in PD. © 2011 Movement Disorder Society The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients.BACKGROUNDThe previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's disease (PD) patients.To extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea.OBJECTIVETo extend the scale so that it becomes a frequency measure scale with five categories and encompasses unmet needs such as restless legs syndrome, akinesia, pain, and sleep apnea.For validation of the PDSS-2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS-2 was repeated for test-retest-reliability after 1-3 days.METHODSFor validation of the PDSS-2, PD patients' ratings and investigators' interviews were compared to ratings from a semistructured interview with a caregiver/partner, and to related scales. PDSS-2 was repeated for test-retest-reliability after 1-3 days.A total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2-40) indicating mild to moderate sleep disturbances. PDSS-2 item-total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) "motor problems at night," (2) "PD symptoms at night" and (3) "disturbed sleep." The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test-retest-reliability intra-class-coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS-2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out.RESULTSA total of 113 PD patients showed a mean (SD) total score of 16.5 (±8.9) (range: 2-40) indicating mild to moderate sleep disturbances. PDSS-2 item-total correlation for proving internal consistency was satisfactory (correlations >0.30). From a factor analysis, three subscales were derived: (1) "motor problems at night," (2) "PD symptoms at night" and (3) "disturbed sleep." The alpha coefficient for the total score was 0.73, for subscales 0.47 to 0.66. The test-retest-reliability intra-class-coefficient for the total score was 0.80, with 0.69 and 0.77 within the subscales. For discriminative validity, significant differences were found in the PDSS-2 total score depending on CGI and Hoehn and Yahr severity levels. A comparison between caregivers' and patients' ratings was carried out.The PDSS-2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment-responsive tool for measuring sleep disorders in PD.CONCLUSIONThe PDSS-2, with an extended spectrum of nocturnal disabilities and easier use for patients, is a reliable, valid, precise, and potentially treatment-responsive tool for measuring sleep disorders in PD.
Author	Sixel-Döring, Friederike Högl, Birgit Kohnen, Ralf Martinez-Martin, Pablo Chaudhuri, Kallol Ray Hülsmann, Julia Trenkwalder, Claudia Frauscher, Birgit Metta, Vinod
Author_xml	– sequence: 1 givenname: Claudia surname: Trenkwalder fullname: Trenkwalder, Claudia email: ctrenkwalder@gmx.de organization: Paracelsus-Elena Hospital, Kassel, Germany – sequence: 2 givenname: Ralf surname: Kohnen fullname: Kohnen, Ralf organization: Research Pharmaceutical Services Inc., Fort Washington, Pennsylvania, USA – sequence: 3 givenname: Birgit surname: Högl fullname: Högl, Birgit organization: Department of Neurology, University Hospital, Innsbruck, Austria – sequence: 4 givenname: Vinod surname: Metta fullname: Metta, Vinod organization: National Parkinson Foundation Centre of Excellence, Kings College Hospital, London, United Kingdom – sequence: 5 givenname: Friederike surname: Sixel-Döring fullname: Sixel-Döring, Friederike organization: Paracelsus-Elena Hospital, Kassel, Germany – sequence: 6 givenname: Birgit surname: Frauscher fullname: Frauscher, Birgit organization: Department of Neurology, University Hospital, Innsbruck, Austria – sequence: 7 givenname: Julia surname: Hülsmann fullname: Hülsmann, Julia organization: Research Pharmaceutical Services Inc., Fort Washington, Pennsylvania, USA – sequence: 8 givenname: Pablo surname: Martinez-Martin fullname: Martinez-Martin, Pablo organization: National Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain – sequence: 9 givenname: Kallol Ray surname: Chaudhuri fullname: Chaudhuri, Kallol Ray organization: National Parkinson Foundation Centre of Excellence, Kings College Hospital, London, United Kingdom
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/21312275$$D View this record in MEDLINE/PubMed
BookMark	eNp90U1PGzEQBmALgSB8HPoHqpV6iDgs7NjrtXOsSEtAQIG06tFy1rOq6WY3eDYB_j0OCRwitaeRrOcdWe_ss-2mbZCxT5CdQJbx06mjEy5yVWyxHkgBqeZSbbNeprVMBWi5x_aJHrIMQEKxy_Y4COBcyR4b3drw1zfUNn1KnCe0hAnViLOESltjurC1d7bzbZO0VdL9wSTgIjqXLDDQ8vl2OB6n_JDtVLYmPFrPA_br-7efZ6P06sf5xdnXq7TMZVGk3CHoglcg0FWlknqg9aCUiANupXKlc5UTCqzO5aSwdqJFnJGjFroQAsQB66_2zkL7OEfqzNRTiXVtG2znZKLKuZa5ivLLhnxo56GJnzOgVKZBcb3c93mt5pMpOjMLfmrDi3mvKILjFShDSxSw-iCQmWX9JtZv3uqP9nTDlr57K68L1tf_Szz5Gl_-vdpcD8fviXSV8NTh80cintEUSihpft-cmzs5uleXlwMzFq903KMK
CODEN	MOVDEA
CitedBy_id	crossref_primary_10_1007_s10072_011_0826_7 crossref_primary_10_5507_bp_2021_002 crossref_primary_10_1007_s11818_024_00450_x crossref_primary_10_3389_fnagi_2021_770920 crossref_primary_10_1007_s11357_022_00530_6 crossref_primary_10_1212_WNL_0b013e3182a6cbd5 crossref_primary_10_4061_2011_219056 crossref_primary_10_1016_j_clineuro_2024_108640 crossref_primary_10_3233_JPD_230168 crossref_primary_10_1002_mds_30244 crossref_primary_10_1186_1471_2377_13_18 crossref_primary_10_1016_j_jsmc_2012_10_004 crossref_primary_10_1007_s40120_022_00371_7 crossref_primary_10_1097_WNF_0000000000000110 crossref_primary_10_1016_j_parkreldis_2024_106012 crossref_primary_10_1016_j_sleep_2019_08_010 crossref_primary_10_1186_s12883_025_04225_1 crossref_primary_10_1111_ene_13529 crossref_primary_10_1016_j_parkreldis_2024_107103 crossref_primary_10_3389_fneur_2021_758481 crossref_primary_10_1186_s12883_022_02647_9 crossref_primary_10_1111_jgs_12458 crossref_primary_10_1002_mds_70009 crossref_primary_10_1038_s41598_018_30128_y crossref_primary_10_1159_000355019 crossref_primary_10_1517_14656566_2013_849692 crossref_primary_10_3389_fmedt_2022_922218 crossref_primary_10_3389_fnins_2020_00689 crossref_primary_10_1007_s40675_017_0079_y crossref_primary_10_1016_j_sleep_2012_06_009 crossref_primary_10_31083_j_jin2311202 crossref_primary_10_1186_s13063_024_08265_9 crossref_primary_10_3390_jpm13071053 crossref_primary_10_1016_j_jocn_2021_07_011 crossref_primary_10_1186_s12883_020_02024_4 crossref_primary_10_1155_2022_1216975 crossref_primary_10_1007_s12035_024_04400_4 crossref_primary_10_1016_j_baga_2013_01_057 crossref_primary_10_1016_j_ncl_2024_12_008 crossref_primary_10_3389_fneur_2019_00340 crossref_primary_10_1016_j_baga_2012_05_009 crossref_primary_10_1186_s12916_023_03176_z crossref_primary_10_1016_j_parkreldis_2022_08_018 crossref_primary_10_3233_JPD_230263 crossref_primary_10_1111_bjc_12354 crossref_primary_10_1016_j_jocn_2025_111635 crossref_primary_10_1038_s41597_023_02663_5 crossref_primary_10_1097_CM9_0000000000002229 crossref_primary_10_3390_jpm13060915 crossref_primary_10_1007_s11910_018_0838_2 crossref_primary_10_1016_j_jpsychores_2018_04_002 crossref_primary_10_1016_j_parkreldis_2014_10_005 crossref_primary_10_1111_ggi_12571 crossref_primary_10_31083_j_jin2205132 crossref_primary_10_1007_s00415_025_12931_6 crossref_primary_10_1097_JNN_0000000000000733 crossref_primary_10_3389_fneur_2018_00961 crossref_primary_10_1016_j_neurol_2013_05_004 crossref_primary_10_1002_mdc3_70046 crossref_primary_10_1016_j_sleep_2016_06_026 crossref_primary_10_1186_s12883_019_1431_2 crossref_primary_10_1017_S1355617722000182 crossref_primary_10_1016_j_jns_2024_122890 crossref_primary_10_1007_s00415_024_12730_5 crossref_primary_10_1093_ije_dys202 crossref_primary_10_1155_2015_970534 crossref_primary_10_1016_j_parkreldis_2018_11_024 crossref_primary_10_3233_JPD_212749 crossref_primary_10_3390_brainsci14060556 crossref_primary_10_1038_s41531_024_00800_4 crossref_primary_10_1002_mdc3_13587 crossref_primary_10_1177_03000605241304646 crossref_primary_10_1097_NPT_0000000000000169 crossref_primary_10_1111_ane_12347 crossref_primary_10_1186_s12906_023_04296_y crossref_primary_10_1002_mdc3_12591 crossref_primary_10_1007_s15005_017_1933_7 crossref_primary_10_1016_j_expneurol_2012_08_018 crossref_primary_10_1016_j_smrv_2016_08_001 crossref_primary_10_1016_j_jsmc_2025_06_002 crossref_primary_10_1038_s41531_025_00985_2 crossref_primary_10_1055_a_1958_0710 crossref_primary_10_1159_000353560 crossref_primary_10_1002_mds_24957 crossref_primary_10_1155_2014_806169 crossref_primary_10_3390_medicina61040591 crossref_primary_10_1136_bmjopen_2020_041303 crossref_primary_10_1007_s10072_015_2409_5 crossref_primary_10_1016_j_parkreldis_2024_106064 crossref_primary_10_3389_fnagi_2023_1264143 crossref_primary_10_1038_s41598_023_48209_y crossref_primary_10_1080_14737175_2025_2450789 crossref_primary_10_1111_jsr_12673 crossref_primary_10_1177_17562864231161163 crossref_primary_10_1080_14737167_2021_1841638 crossref_primary_10_3390_jpm14030298 crossref_primary_10_1007_s10072_019_03785_8 crossref_primary_10_1155_2016_3724148 crossref_primary_10_1016_j_exger_2025_112762 crossref_primary_10_1002_mds_28745 crossref_primary_10_1371_journal_pone_0255274 crossref_primary_10_3233_JPD_191862 crossref_primary_10_1155_2016_4040185 crossref_primary_10_1016_j_sleep_2013_02_016 crossref_primary_10_1007_s11910_015_0525_5 crossref_primary_10_1007_s00415_021_10813_1 crossref_primary_10_1016_j_neuropharm_2022_108959 crossref_primary_10_1038_s41531_025_01031_x crossref_primary_10_1002_mdc3_12694 crossref_primary_10_1007_s11547_025_02025_8 crossref_primary_10_1093_sleep_zsaf005 crossref_primary_10_1038_s41591_024_03428_2 crossref_primary_10_1016_j_parkreldis_2018_12_026 crossref_primary_10_1111_cns_14867 crossref_primary_10_1159_000539330 crossref_primary_10_1016_j_sleep_2021_02_036 crossref_primary_10_1038_s41386_019_0448_y crossref_primary_10_1016_j_parkreldis_2018_01_008 crossref_primary_10_3233_JPD_202101 crossref_primary_10_1016_S1474_4422_22_00085_0 crossref_primary_10_1038_s41598_020_64645_6 crossref_primary_10_1002_mds_28533 crossref_primary_10_1016_j_conctc_2019_100397 crossref_primary_10_1016_j_jns_2012_03_022 crossref_primary_10_1002_brb3_2336 crossref_primary_10_1016_j_jns_2011_05_006 crossref_primary_10_1016_j_parkreldis_2017_08_007 crossref_primary_10_1155_2015_507948 crossref_primary_10_1038_s41598_019_55427_w crossref_primary_10_1097_CM9_0000000000001211 crossref_primary_10_3390_bioengineering12070773 crossref_primary_10_1007_s10072_015_2288_9 crossref_primary_10_1016_j_jns_2018_08_003 crossref_primary_10_1016_j_sleep_2023_09_009 crossref_primary_10_1007_s00415_021_10419_7 crossref_primary_10_1212_WNL_0000000000012968 crossref_primary_10_1007_s41105_015_0024_8 crossref_primary_10_1111_ene_16503 crossref_primary_10_3390_jcm12237397 crossref_primary_10_1097_WNF_0000000000000501 crossref_primary_10_1038_s41531_017_0038_9 crossref_primary_10_1007_s11940_019_0596_8 crossref_primary_10_1080_14737175_2017_1385393 crossref_primary_10_1007_s10072_022_06111_x crossref_primary_10_1155_2021_8834950 crossref_primary_10_1155_2012_205471 crossref_primary_10_1016_j_sleep_2020_10_021 crossref_primary_10_1136_jnnp_2017_316136 crossref_primary_10_1080_09638288_2025_2453636 crossref_primary_10_1586_14737175_2013_859986 crossref_primary_10_3390_jpm12020322 crossref_primary_10_1016_j_parkreldis_2016_08_006 crossref_primary_10_1007_s00415_011_5933_0 crossref_primary_10_1016_j_neuros_2025_100007 crossref_primary_10_1002_mds_26929 crossref_primary_10_1016_j_neulet_2020_135620 crossref_primary_10_4274_jtsm_galenos_2022_29200 crossref_primary_10_1016_j_parkreldis_2012_04_010 crossref_primary_10_1517_14656566_2011_604031 crossref_primary_10_1155_2015_131508 crossref_primary_10_1002_mds_29517 crossref_primary_10_36290_neu_2017_062 crossref_primary_10_1136_bmjopen_2022_071380 crossref_primary_10_1155_2013_258390 crossref_primary_10_1016_j_sleep_2011_06_023 crossref_primary_10_3389_fphar_2021_650597 crossref_primary_10_1186_s12883_024_03548_9 crossref_primary_10_1007_s00415_017_8491_2 crossref_primary_10_3389_fnhum_2021_711703 crossref_primary_10_1002_mds_26281 crossref_primary_10_3389_fmed_2016_00035 crossref_primary_10_1155_2020_9131474 crossref_primary_10_3389_fneur_2022_932199 crossref_primary_10_3389_fneur_2023_1105650 crossref_primary_10_1007_s00415_021_10726_z crossref_primary_10_3389_fnagi_2022_784314 crossref_primary_10_3390_brainsci11121566 crossref_primary_10_4103_0028_3886_388103 crossref_primary_10_14235_bas_galenos_2023_97752 crossref_primary_10_1007_s10072_019_04206_6 crossref_primary_10_1111_jsr_70193 crossref_primary_10_1016_j_euf_2020_02_007 crossref_primary_10_1002_mds_26270 crossref_primary_10_1111_ane_12075 crossref_primary_10_1016_j_clineuro_2025_108794 crossref_primary_10_1111_cns_13984 crossref_primary_10_1007_s11682_024_00862_1 crossref_primary_10_1371_journal_pone_0192394 crossref_primary_10_1155_2015_475630 crossref_primary_10_1136_bmjopen_2023_077766 crossref_primary_10_1016_j_neuropsychologia_2023_108698 crossref_primary_10_1016_j_smrv_2020_101384 crossref_primary_10_3389_fpsyg_2021_763350 crossref_primary_10_1016_j_neurol_2023_08_018 crossref_primary_10_3389_fncel_2024_1459884 crossref_primary_10_3389_fneur_2018_00697 crossref_primary_10_1002_mdc3_12899 crossref_primary_10_1016_j_jsmc_2021_03_001 crossref_primary_10_1016_j_parkreldis_2018_09_023 crossref_primary_10_1186_s12883_021_02217_5 crossref_primary_10_1007_s10072_021_05622_3 crossref_primary_10_1155_2022_7403627 crossref_primary_10_1016_j_jns_2011_10_025 crossref_primary_10_1093_ptj_pzad073 crossref_primary_10_3389_fpsyg_2020_00743 crossref_primary_10_3389_fneur_2025_1591537 crossref_primary_10_1007_s00415_012_6505_7 crossref_primary_10_1002_mdc3_12749 crossref_primary_10_1038_s41531_017_0009_1 crossref_primary_10_1016_j_pneurobio_2024_102603 crossref_primary_10_1371_journal_pone_0132368 crossref_primary_10_3346_jkms_2018_33_e14 crossref_primary_10_1002_mds_26731 crossref_primary_10_1007_s11845_022_03144_1 crossref_primary_10_1002_mds_28115 crossref_primary_10_4103_aian_aian_255_22 crossref_primary_10_1111_ene_13567 crossref_primary_10_3109_00207454_2014_966820 crossref_primary_10_3390_medicines4020023 crossref_primary_10_3389_fneur_2018_00360 crossref_primary_10_3390_brainsci14040397 crossref_primary_10_5014_ajot_2022_763001 crossref_primary_10_1038_s41531_025_01046_4 crossref_primary_10_1002_mds_30214 crossref_primary_10_1080_07317115_2024_2306861 crossref_primary_10_1016_j_ncl_2019_12_003 crossref_primary_10_1055_s_0044_1791977 crossref_primary_10_1177_08919887251366638 crossref_primary_10_1002_mdc3_14018 crossref_primary_10_3389_fneur_2019_01114 crossref_primary_10_1080_01616412_2023_2258038 crossref_primary_10_1177_20552076221119327 crossref_primary_10_1007_s13311_020_00938_y crossref_primary_10_1016_j_parkreldis_2025_107934 crossref_primary_10_1111_ene_13691 crossref_primary_10_3389_fneur_2017_00042 crossref_primary_10_1155_2021_2015123 crossref_primary_10_1016_j_sleep_2025_02_031 crossref_primary_10_3389_fneur_2018_00369 crossref_primary_10_1186_1471_2377_14_42 crossref_primary_10_1007_s00415_021_10651_1 crossref_primary_10_1080_14656566_2018_1480721 crossref_primary_10_1016_j_ctcp_2020_101169 crossref_primary_10_1002_mds_26511 crossref_primary_10_1016_j_neubiorev_2016_06_036 crossref_primary_10_3390_brainsci13081202 crossref_primary_10_1177_1877718X241306711 crossref_primary_10_1017_S1355617722000388 crossref_primary_10_1080_15402002_2019_1629445 crossref_primary_10_1007_s00415_024_12351_y crossref_primary_10_1016_j_cct_2013_06_002 crossref_primary_10_1111_nyas_12508 crossref_primary_10_1007_s10072_018_3397_z crossref_primary_10_1186_s12883_019_1355_x
Cites_doi	10.1002/mds.22110 10.1016/j.jclinepi.2007.03.012 10.1007/s10072-003-0134-y 10.1136/jnnp.51.6.745 10.1016/j.jns.2009.09.015 10.1212/01.WNL.0000058905.71369.97 10.1136/jnnp.2008.166629 10.1093/oso/9780198528470.001.0001 10.1136/jnnp.2008.166959 10.1207/s15327906mbr1203_2 10.1111/j.1469-8986.1973.tb00801.x 10.1002/mds.21682 10.1016/j.parkreldis.2005.02.006 10.1002/mds.20808 10.1002/mds.20144 10.1002/mds.22731 10.1002/ana.410340514 10.1093/sleep/14.6.540 10.1023/A:1023499322593 10.1002/mds.21257 10.1016/j.jns.2008.04.008 10.1001/jama.287.4.455 10.1016/j.parkreldis.2008.02.002 10.1097/WCO.0b013e328305044d 10.1159/000058047 10.1212/WNL.59.4.585 10.1016/0165-1781(89)90047-4 10.1207/s15327906mbr0102_10 10.1212/WNL.58.7.1019 10.1016/j.jclinepi.2007.05.011 10.1007/s11910-003-0073-2 10.1016/j.sleep.2008.05.004 10.1016/j.jns.2006.05.004 10.1002/mds.23190 10.1136/jnnp.73.6.629 10.1002/mds.21198
ContentType	Journal Article
Copyright	Copyright © 2011 Movement Disorder Society Copyright © 2011 Movement Disorder Society.
Copyright_xml	– notice: Copyright © 2011 Movement Disorder Society – notice: Copyright © 2011 Movement Disorder Society.
DBID	BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8
DOI	10.1002/mds.23476
DatabaseName	Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic
DatabaseTitleList	MEDLINE Nursing & Allied Health Premium MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1531-8257
EndPage	652
ExternalDocumentID	3972320311 21312275 10_1002_mds_23476 MDS23476 ark_67375_WNG_Q5HR7JJ9_S
Genre	article Journal Article
GroupedDBID	--- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XV2 ZGI ZZTAW ~IA ~WT AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE RWD RWI WRC WUP YCJ AAYXX CITATION O8X CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8
ID	FETCH-LOGICAL-c4566-2de1862f13edfc7589889c5ee92a57dcddfd371a845b6aab835b62f1e83863313
IEDL.DBID	DRFUL
ISICitedReferencesCount	304
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000290444800014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0885-3185 1531-8257
IngestDate	Thu Oct 02 10:51:26 EDT 2025 Sat Nov 29 14:45:02 EST 2025 Mon Jul 21 05:50:00 EDT 2025 Sat Nov 29 07:07:03 EST 2025 Tue Nov 18 20:58:44 EST 2025 Wed Jan 22 16:38:04 EST 2025 Sun Sep 21 06:18:33 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2011 Movement Disorder Society.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4566-2de1862f13edfc7589889c5ee92a57dcddfd371a845b6aab835b62f1e83863313
Notes	ArticleID:MDS23476 istex:868E1244F07D5212CAB8F1057CC6C2E61C372911 ark:/67375/WNG-Q5HR7JJ9-S Relevant conflict of interest/financial disclosure: Nothing to report. Full financial disclosures and author roles can be found in the online version of this article. Author Roles and Disclosures Relevant conflict of interest/financial disclosure Nothing to report. Full financial disclosures and author roles can be found in the online version of this article. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
PMID	21312275
PQID	1770817281
PQPubID	1016421
PageCount	9
ParticipantIDs	proquest_miscellaneous_863428547 proquest_journals_1770817281 pubmed_primary_21312275 crossref_primary_10_1002_mds_23476 crossref_citationtrail_10_1002_mds_23476 wiley_primary_10_1002_mds_23476_MDS23476 istex_primary_ark_67375_WNG_Q5HR7JJ9_S
PublicationCentury	2000
PublicationDate	March 2011
PublicationDateYYYYMMDD	2011-03-01
PublicationDate_xml	– month: 03 year: 2011 text: March 2011
PublicationDecade	2010
PublicationPlace	Hoboken
PublicationPlace_xml	– name: Hoboken – name: United States
PublicationTitle	Movement disorders
PublicationTitleAlternate	Mov. Disord
PublicationYear	2011
Publisher	Wiley Subscription Services, Inc., A Wiley Company Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley Subscription Services, Inc
References	Uemura Y, Nomura T, Inoue Y, Yamawaki M, Yasui K, Nakashima K. Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh sleep quality index, the Epworth sleepiness scale and polysomnography. J Neurol Sci 2009; 287: 36-40. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752. Wang G, Cheng Q, Zeng J, et al. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale. J Neurol Sci 2008; 271: 153-157. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59: 585-589. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, Fourth ed. Washington, DC: American Psychiatric Association, 2000. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-635. Arnulf I, Leu S, Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol 2008; 21: 472-477. Schrag A, Geser F, Stampfer-Kountchev M, et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006; 21: 809-815. Okuma Y, Kamei S, Morita A, et al. Fatigue in Japanese patients with Parkinson's disease: a study using Parkinson fatigue scale. Mov Disord 2009; 24: 1977-1983. Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930. Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med 2009; 10: 407-415. Comella CL. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007; 22( Suppl 17): S367-S373. Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22: 41-47. Högl B, Arnulf I, Comella C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Movement Disord 2010; 25: 2704-2716. Cattell RB, Vogelmann S. A comprehensive trial of the Scree and KG criteria for determining the number of factors. Multivariate Behav Res 1977; 12: 289-325. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002; 58: 1019-1024. Rejas J, Pardo A, Ruiz MA. Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures. J Clin Epidemiol 2008; 61: 350-356. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 2003; 24: 209-210. Martinez-Martin P, Salvador C, Menendez-Guisasola L, et al. Parkinson's disease sleep scale: validation study of a Spanish version. Mov Disord 2004; 19: 1226-1232. Martinez-Martin P, Visser M, Rodriguez-Blazquez C, Marinus J, Chaudhuri KR, van Hilten JJ. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 2008; 23: 1681-1688. Tse W, Liu Y, Barthlen GM, et al. Clinical usefulness of the Parkinson's disease sleep scale. Parkinsonism Relat Disord 2005; 11: 317-321. Suzuki K, Miyamoto M, Miyamoto T, et al. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 15-19. Merino-Andreu M, Arnulf I, Konofal E, Derenne JP, Agid Y. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 2003; 60: 1553-1554. Chaudhuri KR, Pal S, Bridgman K, Trenkwalder C. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability. Eur Neurol 2001; 46( Suppl 1): 3-10. Comella CL. Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 2003; 3: 173-180. Suzuki K, Okuma Y, Hattori N, et al. Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale. Mov Disord 2007; 22: 1245-1251. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993; 34: 710-714. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, Third ed. Oxford: Oxford University Press; 2003. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-109. Dhawan V, Dhoat S, Williams AJ, et al. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. J Neurol Sci 2006; 248: 158-162. Tanasanvimon S, Ayuthaya NI, Phanthumchinda K. Modified Parkinson's disease sleep scale (MPDSS) in Thai Parkinson's disease patients. J Med Assoc Thai 2007; 90: 2277-2283. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002; 287: 455-463. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-436. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545. Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 245. Buysse DJ, Reynolds CF,III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213. van Rooden SM, Visser M, Verbaan D, Marinus J, van Hilten JJ. Patterns of motor and non-motor features in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 846-850. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003; 12: 349-362. 2002; 58 2002; 59 1966; 1 2009; 24 1991; 14 2009; 80 1973; 10 2002; 73 2009 2007; 90 1988; 51 2003 2001; 46 1989; 28 2003; 12 1993; 34 2010; 25 2009; 10 2000 2004; 19 2006; 21 2002; 287 2003; 24 2009; 287 2003; 3 2008; 23 2008; 21 1977; 12 2006; 248 2003; 60 2008; 61 2007; 22 2005; 11 2009; 15 2008; 271 American Psychiatric Association (e_1_2_6_19_2) 2000 e_1_2_6_31_2 e_1_2_6_18_2 Trenkwalder C (e_1_2_6_6_2) e_1_2_6_12_2 e_1_2_6_35_2 e_1_2_6_13_2 e_1_2_6_34_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_16_2 e_1_2_6_39_2 e_1_2_6_17_2 e_1_2_6_38_2 e_1_2_6_14_2 e_1_2_6_37_2 e_1_2_6_15_2 e_1_2_6_36_2 e_1_2_6_20_2 e_1_2_6_41_2 e_1_2_6_40_2 e_1_2_6_8_2 e_1_2_6_7_2 Tanasanvimon S (e_1_2_6_30_2) 2007; 90 e_1_2_6_9_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2
References_xml	– reference: Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007; 22: 41-47. – reference: Arnulf I, Leu S, Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol 2008; 21: 472-477. – reference: Wang G, Cheng Q, Zeng J, et al. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale. J Neurol Sci 2008; 271: 153-157. – reference: Comella CL. Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 2003; 3: 173-180. – reference: Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002; 58: 1019-1024. – reference: Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 245. – reference: Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, Third ed. Oxford: Oxford University Press; 2003. – reference: Tse W, Liu Y, Barthlen GM, et al. Clinical usefulness of the Parkinson's disease sleep scale. Parkinsonism Relat Disord 2005; 11: 317-321. – reference: van Rooden SM, Visser M, Verbaan D, Marinus J, van Hilten JJ. Patterns of motor and non-motor features in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 846-850. – reference: Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 2003; 24: 209-210. – reference: Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-635. – reference: Schrag A, Geser F, Stampfer-Kountchev M, et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006; 21: 809-815. – reference: Tanasanvimon S, Ayuthaya NI, Phanthumchinda K. Modified Parkinson's disease sleep scale (MPDSS) in Thai Parkinson's disease patients. J Med Assoc Thai 2007; 90: 2277-2283. – reference: Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-436. – reference: Cattell RB, Vogelmann S. A comprehensive trial of the Scree and KG criteria for determining the number of factors. Multivariate Behav Res 1977; 12: 289-325. – reference: Okuma Y, Kamei S, Morita A, et al. Fatigue in Japanese patients with Parkinson's disease: a study using Parkinson fatigue scale. Mov Disord 2009; 24: 1977-1983. – reference: Chaudhuri KR, Pal S, Bridgman K, Trenkwalder C. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability. Eur Neurol 2001; 46( Suppl 1): 3-10. – reference: Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545. – reference: Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993; 34: 710-714. – reference: Merino-Andreu M, Arnulf I, Konofal E, Derenne JP, Agid Y. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 2003; 60: 1553-1554. – reference: Suzuki K, Miyamoto M, Miyamoto T, et al. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. Parkinsonism Relat Disord 2009; 15: 15-19. – reference: Uemura Y, Nomura T, Inoue Y, Yamawaki M, Yasui K, Nakashima K. Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh sleep quality index, the Epworth sleepiness scale and polysomnography. J Neurol Sci 2009; 287: 36-40. – reference: American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, Fourth ed. Washington, DC: American Psychiatric Association, 2000. – reference: Martinez-Martin P, Salvador C, Menendez-Guisasola L, et al. Parkinson's disease sleep scale: validation study of a Spanish version. Mov Disord 2004; 19: 1226-1232. – reference: Rejas J, Pardo A, Ruiz MA. Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures. J Clin Epidemiol 2008; 61: 350-356. – reference: Comella CL. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007; 22( Suppl 17): S367-S373. – reference: Högl B, Arnulf I, Comella C, et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Movement Disord 2010; 25: 2704-2716. – reference: Dhawan V, Dhoat S, Williams AJ, et al. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. J Neurol Sci 2006; 248: 158-162. – reference: Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003; 12: 349-362. – reference: Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002; 287: 455-463. – reference: Martinez-Martin P, Visser M, Rodriguez-Blazquez C, Marinus J, Chaudhuri KR, van Hilten JJ. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 2008; 23: 1681-1688. – reference: Buysse DJ, Reynolds CF,III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213. – reference: Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752. – reference: Aarsland D, Bronnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930. – reference: Suzuki K, Okuma Y, Hattori N, et al. Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale. Mov Disord 2007; 22: 1245-1251. – reference: Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61: 102-109. – reference: Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med 2009; 10: 407-415. – reference: Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59: 585-589. – volume: 59 start-page: 585 year: 2002 end-page: 589 article-title: REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease publication-title: Neurology – volume: 287 start-page: 455 year: 2002 end-page: 463 article-title: Excessive daytime sleepiness and sudden‐onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group publication-title: JAMA – year: 2009 – volume: 61 start-page: 102 year: 2008 end-page: 109 article-title: Recommended methods for determining responsiveness and minimally important differences for patient‐reported outcomes publication-title: J Clin Epidemiol – volume: 11 start-page: 317 year: 2005 end-page: 321 article-title: Clinical usefulness of the Parkinson's disease sleep scale publication-title: Parkinsonism Relat Disord – volume: 24 start-page: 209 year: 2003 end-page: 210 article-title: Health‐related quality of life and sleep disorders in Parkinson's disease publication-title: Neurol Sci – volume: 58 start-page: 1019 year: 2002 end-page: 1024 article-title: Parkinson's disease and sleepiness: an integral part of PD publication-title: Neurology – year: 2003 – volume: 80 start-page: 846 year: 2009 end-page: 850 article-title: Patterns of motor and non‐motor features in Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – year: 2000 – volume: 12 start-page: 349 year: 2003 end-page: 362 article-title: On assessing responsiveness of health‐related quality of life instruments: guidelines for instrument evaluation publication-title: Qual Life Res – volume: 21 start-page: 809 year: 2006 end-page: 815 article-title: Health‐related quality of life in multiple system atrophy publication-title: Mov Disord – volume: 51 start-page: 745 year: 1988 end-page: 752 article-title: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 34 start-page: 710 year: 1993 end-page: 714 article-title: Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations publication-title: Ann Neurol – volume: 60 start-page: 1553 year: 2003 end-page: 1554 article-title: Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness publication-title: Neurology – volume: 15 start-page: 15 year: 2009 end-page: 19 article-title: Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease publication-title: Parkinsonism Relat Disord – volume: 23 start-page: 1681 year: 2008 end-page: 1688 article-title: SCOPA‐sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease publication-title: Mov Disord – volume: 10 start-page: 431 year: 1973 end-page: 436 article-title: Quantification of sleepiness: a new approach publication-title: Psychophysiology – volume: 22 start-page: 1245 year: 2007 end-page: 1251 article-title: Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale publication-title: Mov Disord – volume: 73 start-page: 629 year: 2002 end-page: 635 article-title: The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 10 start-page: 407 year: 2009 end-page: 415 article-title: Polysomnographic findings, video‐based sleep analysis and sleep perception in progressive supranuclear palsy publication-title: Sleep Med – volume: 12 start-page: 289 year: 1977 end-page: 325 article-title: A comprehensive trial of the Scree and KG criteria for determining the number of factors publication-title: Multivariate Behav Res – volume: 271 start-page: 153 year: 2008 end-page: 157 article-title: Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale publication-title: J Neurol Sci – volume: 21 start-page: 472 year: 2008 end-page: 477 article-title: Abnormal sleep and sleepiness in Parkinson's disease publication-title: Curr Opin Neurol – volume: 14 start-page: 540 year: 1991 end-page: 545 article-title: A new method for measuring daytime sleepiness: the Epworth sleepiness scale publication-title: Sleep – volume: 1 start-page: 245 year: 1966 article-title: The scree test for the number of factors publication-title: Multivariate Behav Res – volume: 22 start-page: 41 year: 2007 end-page: 47 article-title: Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan publication-title: Mov Disord – volume: 61 start-page: 350 year: 2008 end-page: 356 article-title: Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient‐reported outcomes measures publication-title: J Clin Epidemiol – volume: 3 start-page: 173 year: 2003 end-page: 180 article-title: Sleep disturbances in Parkinson's disease publication-title: Curr Neurol Neurosci Rep – volume: 90 start-page: 2277 year: 2007 end-page: 2283 article-title: Modified Parkinson's disease sleep scale (MPDSS) in Thai Parkinson's disease patients publication-title: J Med Assoc Thai – volume: 28 start-page: 193 year: 1989 end-page: 213 article-title: The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research publication-title: Psychiatry Res – volume: 24 start-page: 1977 year: 2009 end-page: 1983 article-title: Fatigue in Japanese patients with Parkinson's disease: a study using Parkinson fatigue scale publication-title: Mov Disord – volume: 80 start-page: 928 year: 2009 end-page: 930 article-title: The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 22 start-page: S367 issue: Suppl 17 year: 2007 end-page: S373 article-title: Sleep disorders in Parkinson's disease: an overview publication-title: Mov Disord – volume: 19 start-page: 1226 year: 2004 end-page: 1232 article-title: Parkinson's disease sleep scale: validation study of a Spanish version publication-title: Mov Disord – volume: 248 start-page: 158 year: 2006 end-page: 162 article-title: The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography publication-title: J Neurol Sci – volume: 46 start-page: 3 issue: Suppl 1 year: 2001 end-page: 10 article-title: Achieving 24‐hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability publication-title: Eur Neurol – volume: 25 start-page: 2704 year: 2010 end-page: 2716 article-title: Scales to assess sleep impairment in Parkinson's disease: critique and recommendations publication-title: Movement Disord – volume: 287 start-page: 36 year: 2009 end-page: 40 article-title: Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh sleep quality index, the Epworth sleepiness scale and polysomnography publication-title: J Neurol Sci – ident: e_1_2_6_11_2 doi: 10.1002/mds.22110 – ident: e_1_2_6_40_2 doi: 10.1016/j.jclinepi.2007.03.012 – ident: e_1_2_6_27_2 doi: 10.1007/s10072-003-0134-y – ident: e_1_2_6_18_2 doi: 10.1136/jnnp.51.6.745 – ident: e_1_2_6_10_2 doi: 10.1016/j.jns.2009.09.015 – volume-title: Principles and practice of sleep medicine ident: e_1_2_6_6_2 – ident: e_1_2_6_37_2 doi: 10.1212/01.WNL.0000058905.71369.97 – ident: e_1_2_6_25_2 doi: 10.1136/jnnp.2008.166629 – ident: e_1_2_6_20_2 doi: 10.1093/oso/9780198528470.001.0001 – ident: e_1_2_6_2_2 doi: 10.1136/jnnp.2008.166959 – ident: e_1_2_6_22_2 doi: 10.1207/s15327906mbr1203_2 – ident: e_1_2_6_14_2 doi: 10.1111/j.1469-8986.1973.tb00801.x – ident: e_1_2_6_35_2 doi: 10.1002/mds.21682 – ident: e_1_2_6_15_2 doi: 10.1016/j.parkreldis.2005.02.006 – ident: e_1_2_6_33_2 doi: 10.1002/mds.20808 – ident: e_1_2_6_28_2 doi: 10.1002/mds.20144 – ident: e_1_2_6_38_2 – ident: e_1_2_6_26_2 doi: 10.1002/mds.22731 – ident: e_1_2_6_5_2 doi: 10.1002/ana.410340514 – ident: e_1_2_6_12_2 doi: 10.1093/sleep/14.6.540 – ident: e_1_2_6_39_2 doi: 10.1023/A:1023499322593 – ident: e_1_2_6_24_2 doi: 10.1002/mds.21257 – ident: e_1_2_6_31_2 doi: 10.1016/j.jns.2008.04.008 – ident: e_1_2_6_13_2 doi: 10.1001/jama.287.4.455 – volume-title: Task Force on DSM‐IV. Diagnostic and statistical manual of mental disorders: DSM‐IV‐TR year: 2000 ident: e_1_2_6_19_2 – ident: e_1_2_6_32_2 doi: 10.1016/j.parkreldis.2008.02.002 – ident: e_1_2_6_16_2 doi: 10.1097/WCO.0b013e328305044d – ident: e_1_2_6_17_2 doi: 10.1159/000058047 – ident: e_1_2_6_4_2 doi: 10.1212/WNL.59.4.585 – ident: e_1_2_6_9_2 doi: 10.1016/0165-1781(89)90047-4 – ident: e_1_2_6_21_2 doi: 10.1207/s15327906mbr0102_10 – ident: e_1_2_6_36_2 doi: 10.1212/WNL.58.7.1019 – ident: e_1_2_6_41_2 doi: 10.1016/j.jclinepi.2007.05.011 – ident: e_1_2_6_23_2 doi: 10.1007/s11910-003-0073-2 – ident: e_1_2_6_34_2 doi: 10.1016/j.sleep.2008.05.004 – ident: e_1_2_6_29_2 doi: 10.1016/j.jns.2006.05.004 – ident: e_1_2_6_7_2 doi: 10.1002/mds.23190 – ident: e_1_2_6_8_2 doi: 10.1136/jnnp.73.6.629 – volume: 90 start-page: 2277 year: 2007 ident: e_1_2_6_30_2 article-title: Modified Parkinson's disease sleep scale (MPDSS) in Thai Parkinson's disease patients publication-title: J Med Assoc Thai – ident: e_1_2_6_3_2 doi: 10.1002/mds.21198
SSID	ssj0011516
Score	2.4966664
Snippet	Background: The previous Parkinson's disease sleep scale (PDSS) is a 15‐item visual analogue scale that assesses the profile of nocturnal disturbances in... The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in Parkinson's... Background: The previous Parkinson's disease sleep scale (PDSS) is a 15-item visual analogue scale that assesses the profile of nocturnal disturbances in...
SourceID	proquest pubmed crossref wiley istex
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	644
SubjectTerms	Adult Aged Aged, 80 and over Factor Analysis, Statistical Female Humans Male Middle Aged MOS Movement disorders nocturnal disturbance Parkinson Disease - complications Parkinson's disease PDSS Reproducibility of Results Severity of Illness Index sleep Sleep Wake Disorders - diagnosis Sleep Wake Disorders - etiology Statistics as Topic Surveys and Questionnaires UPDRS validation
Title	Parkinson's disease sleep scale-validation of the revised version PDSS-2
URI	https://api.istex.fr/ark:/67375/WNG-Q5HR7JJ9-S/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.23476 https://www.ncbi.nlm.nih.gov/pubmed/21312275 https://www.proquest.com/docview/1770817281 https://www.proquest.com/docview/863428547
Volume	26
WOSCitedRecordID	wos000290444800014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1531-8257 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011516 issn: 0885-3185 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1faxQxEB_aOxFf6n-7WksQUV-uvSSbTRafxPMspT1qz-K9hWSThUK9K01bfOxH8MFP2E_iZLO3Uqgg-BbILJvMTJLfZDIzAK-doa4WaKaaoXBooOTYcrQaeKO499Hg4HVTbEJOJmo2Kw9W4P0yFiblh-gu3OLKaPbruMCNDdt_koZ-d2GL8VwWq9BnqLd5D_qjw_HRXudEwMOsSCBSNEHCy8RCQ7bdfXzjOOpHzv64DWvehK7N2TO-_1-jfgBrLeQkH5KOPIQVP38Ed_dbp_pj2IuRz00Q2NtAWocNCSfen5KAEvTXV79QHY9T8SWyqAliRhJfBwfvyGW6byMHo-n0-uonewJH409fP-4M2iILgwqxUzFgzlO0amrKvasrtB5KpcpKeF8yI6SrnKsdl9SoXNjCGIuIzUZyr7gqOKf8KfTmi7lfB-KsLaTNZdw0cimsNRatQ888Z9glhxm8W_JaV20G8lgI40Sn3MlMI3d0w50MXnWkpyntxm1EbxqBdRTIrfhOTQr9bfJZfxE7h3J3t9TTDDaWEtXtEg2aSolwSDJFMyBdNy6u6DExc7-4CBpnmMcQU5nBs6QI3b8Y5ZQxKXBSjbz_Pky9P5o2jef_TvoC7qXL6_jYbQN652cX_iXcqS7Pj8PZJqzKmdps1f03N0EBsw
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbhMxcFQSBFx4FlgoYCEEXNLG9nq9K3FBhBBKEpWmFb1Z9torVSpJ1W0rjv0EDv3CfknH9mZRpSIhcbPkWa09D3senhmAN1ZTWwk0U3VfWDRQUhxZWvaczrlz3uDgVWg2IafTfG-v2FqBD8tcmFgfonW4eckI57UXcO-Q3vhTNfSnrdcZT2V2A7opspHoQHewPdwdt1EEvM2yqEWKkCW8rCzUZxvtx1fuo65H7a_rlM2rumu4fIb3_m_Z9-Fuo3SSj5FLHsCKmz-EW5MmrP4Ixj73OaSBvatJE7Ih9YFzh6RGGrqLs3NkyP3YfoksKoJaI_Hvg2tnyWn0uJGtwWx2cfabrcLu8PPOp1GvabPQK1F7ynrMOop2TUW5s1WJ9kOR50UpnCuYFtKW1laWS6rzVJhMa4M6m_HgLud5xjnlj6EzX8zdUyDWmEyaVPpjI5XCGG3QPnTMcYZTsp_A-yWyVdnUIPetMA5UrJ7MFGJHBewk8LoFPYyFN64Dehso1kIgtvxLNSnUj-kX9V2MtuXmZqFmCawtSaoaIa0VlRIVIslymgBpp1G8fMxEz93ipFa4w9QnmcoEnkROaP_FKKeMSYGbCgT_-zLVZDALg2f_DvoKbo92JmM1_jr99hzuRFe2f_q2Bp3joxP3Am6Wp8f79dHLhusvAY11BLs
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fTxQxEJ8gZ4gv4n9WUBtj1JeTa7vd7ia-GM8T8bicnATemu52NiGBuwsLxEc-gg98Qj4J0-7eGhJMTHxr0tlsO3_a33Q6U4A3znJXKnJTbU85clBiajledNGmEtE7HLIMj03o0Sg9OMjGS_BxkQtT14doD9y8ZYT12hs4zl25-adq6LGrPggZ6-QOdGKVJWSWnf7uYG_YRhFoN0tqFKlClvCislBPbLYf39iPOp61v24Dmzexa9h8Bqv_N-wHcL8BnexTrSUPYQmnj2BlpwmrP4ahz30OaWDvKtaEbFh1hDhnFckQry4uSSEP6-eX2KxkhBqZvx9coWPn9YkbG_cnk6uL3-IJ7A2-_Py81W2eWegWhJ6SrnDIya8puURXFuQ_ZGmaFQoxE1ZpVzhXOqm5TWOVJ9bmhNlyT46pTBMpuXwKy9PZFNeAuTxPdB5rv2zEWuW5zck_RIFSUJfuRfB-wWxTNDXI_VMYR6auniwMcccE7kTwuiWd14U3biN6GyTWUhC3_E01rcz-6Kv5obZ29fZ2ZiYRbCxEahojrQzXmgCRFimPgLXdZF4-ZmKnODurDM0w9kmmOoJntSa0_xJcciG0okkFgf99mGanPwmN5_9O-gpWxv2BGX4bfV-He_VJtr_5tgHLpydn-ALuFuenh9XJy0bprwESfAQ2
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Parkinson%27s+disease+sleep+scale-validation+of+the+revised+version+PDSS-2&rft.jtitle=Movement+disorders&rft.au=Trenkwalder%2C+Claudia&rft.au=Kohnen%2C+Ralf&rft.au=H%C3%B6gl%2C+Birgit&rft.au=Metta%2C+Vinod&rft.date=2011-03-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=26&rft.issue=4&rft.spage=644&rft.epage=652&rft_id=info:doi/10.1002%2Fmds.23476&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_Q5HR7JJ9_S
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon